The Regulation of Inflammation by Innate and Adaptive Lymphocytes

Abstract

Inflammation plays an essential role in the control of pathogens and in shaping the ensuing adaptive immune responses. Traditionally, innate immunity has been described as a rapid response triggered through generic and nonspecific means that by definition lacks the ability to remember. Recently, it has become clear that some innate immune cells are epigenetically reprogrammed or “imprinted” by past experiences. These “trained” innate immune cells display altered inflammatory responses upon subsequent pathogen encounter. Remembrance of past pathogen encounters has classically been attributed to cohorts of antigen-specific memory T and B cells following the resolution of infection. During recall responses, memory T and B cells quickly respond by proliferating, producing effector cytokines, and performing various effector functions. An often-overlooked effector function of memory CD4 and CD8 T cells is the promotion of an inflammatory milieu at the initial site of infection that mirrors the primary encounter. This memory-conditioned inflammatory response, in conjunction with other secondary effector T cell functions, results in better control and more rapid resolution of both infection and the associated tissue pathology. Recent advancements in our understanding of inflammatory triggers, imprinting of the innate immune responses, and the role of T cell memory in regulating inflammation are discussed.

Hydrostatic Filtration Enables Large-Scale Production of Outer Membrane Vesicles That Effectively Protect Chickens against Gallibacterium anatis

“…The OMVs exhibit on their surface a variety of pathogen-associated molecular patterns (PAMPs) [13], molecules able to elicit an immune response in the host ultimately by recruiting and activating antigen-presenting cells (APCs) [20]. This process is partly mediated by the release of pro-inflammatory cytokines by host immune effectors, the concentration of which can affect the balance between an inflammatory and adaptive response [41]. Moderate levels of inflammation can potentiate the response to an administered immunogen, and for this reason pro-inflammatory compounds such as adjuvants are generally included in vaccine formulations.…”

New insights into TNFα/PTP1B and PPARγ pathway through RNF213- a link between inflammation, obesity, insulin resistance and Moyamoya disease

“…Raw 264.7 murine macrophages were chosen because they are activated on encountering pathogens similar to dendritic cells. Macrophages engulf these pathogens and digest the antigen into smaller peptides which are presented to CD8 + T cells on MHC class I molecules (Cronkite & Strutt, 2018). Macrophages are also known to secrete inflammatory molecules and trigger inflammation directly (Janeway et al, 2001; N. F. and K. Kobayashi, 2005).…”

Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection

“…Additionally, genes involved in T cell activation (PCBP1, ARPC2), migration (FMNL1), cytotoxic function (GNLY, SRM), transcription factors (LYN), and downstream signal transduction (COTL1) were all reduced in LDs (Fig.3b-c). Given that cytokines are produced by several immune cells, including adaptive T cells 28 , the reduced cytokine levels in LDs are at least partially explained by these ndings. Meanwhile, IFITM2, an interferon (IFN)-stimulated gene (ISG), vital for viral clearance 29 , was downregulated in LDs and may contribute to the longer viral persistence in LDs (Fig.3b-c).…”